Drug intelligence / Profile preview

arginine + glutamine + omega-3 fatty acids

Development stage
Unknown
Lead developer
Emmaus Life Sciences
Modality
Peptides, Small Molecules
Administration
Oral, Enteral
01

Overview

This is a combination of three immunonutrients—arginine, glutamine, and omega-3 fatty acids—used primarily as an enteral nutrition supplement in clinical settings. These nutrients are often included together in specialized medical nutrition formulas designed to support immune function and modulate inflammatory responses during periods of metabolic stress such as surgery or critical illness. Arginine is a conditionally essential amino acid that promotes T lymphocyte proliferation and enhances immune responses through nitric oxide production. Glutamine supports gastrointestinal mucosal integrity, increases lymphocyte counts, and helps prevent bacterial translocation. Omega-3 fatty acids (primarily EPA and DHA) regulate inflammation by modulating cytokine production and increasing natural killer cell activity. This combination has been studied for perioperative nutritional support in patients undergoing major abdominal cancer surgery but has not consistently demonstrated superior immunomodulatory effects compared to standard enteral nutrition[1][2][6]. The mechanism of action involves modulation of immune cell function, enhancement of wound healing processes (via protein synthesis), maintenance of gut barrier integrity, regulation of inflammatory mediators (e.g., cytokines), and improvement in microcirculation.

Other names
arginineglutamineomega-3 fatty acidsomega3 fatty acidsomega 3 fatty acids
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on arginine + glutamine + omega-3 fatty acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arginine + glutamine + omega-3 fatty acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call